Introduction n
Mucosall tissues are heavily populated with cells of the immune system, including dendriticc cells (DC) (1,2). In their immature state, DC are very efficient in antigen capturee and can use several pathways such as macropinocytosis or phagocytosis of viruses,, bacteria (3, 4) , apoptotic and necrotic cell fragments (5, 6), as well as intracellularr parasites (7, 8) . In addition, C-type lectin receptors (mannose receptor, DEC-205)) (9-11) or Fc receptors such as Fey receptor types I (CD64) and II (CD32) (12) (13) (14) ,, and FceR type I (15, 16) are able to mediate endocytosis of immune complexess (IC) or opsonized particles for antigen-presentation in DCs. This event of antigenn uptake, is thought to induce activation, migration and maturation of the DC andd represents the first critical step in the immune response. Dendritic cells of mucosal surfacess have been described to pick up antigen and migrate out of mucosal tissues to drainingg lymph nodes for antigen-presentation to T cells (17) . However, recent studies showw that immature DC migrate constitutively from peripheral tissues in the absence off any antigenic or inflammatory stimuli (18) .
AA prominent feature of immune responses at mucosal sites is the synthesis of IgA. IgAA is mainly expressed in two distinct forms: serum IgA being predominantly monomelic,, and secretory IgA (SIgA) in external fluids, which consists of dimeric IgA containingg a joining J chain and secretory component as a result of the transcytosis processs (19, 20) . SIgA is considered the first line of defence to protect the body againstt incoming pathogens. Since responses against commensal bacterial flora and dietaryy antigens are harmful, SIgA is proposed as a non-or even anti-inflammatory antibodyy (21) (22) (23) (24) . In contrast, serum IgA was shown to initiate effector functions like complementt activation, respiratory burst activity, or phagocytosis (19, 25) .
Interactionn of IgA with FcR for IgA (FcctR) are considered to play an important role in thee protection against infections. The first and best characterized specific receptor for IgAA in humans is the FcaRI (CD89). The expression of human FcocRI has been found onn monocytes, macrophages, granulocytes and eosinophils (20, 26, 27) . However, little informationn exists concerning the CD89 expression on DC populations of myeloid origin.. Myeloid DC have been characterized and in vitro cultures of DC from peripherall blood monocytes and CD34 + selected cells have been established (28, 29) . Inn this study we investigated how CD89 expression is regulated during DC developmentt and studied whether DC can bind and take up IgA.
Wee detected low levels of CD89 expression on a distinct population of CD34 + -derivedd DC and on monocyte-derived DC (MoDC). Binding of SIgA to DC was superiorr to binding of serum IgA and could not be inhibited by anti-CD89 blocking antibodies.. Interestingly, uptake of SIgA was not accompanied by DC maturation. Uptakee of SIgA by DC was highly efficient and could be blocked by specific sugars or partiallyy by Abs reactive with mannose receptor (MR). These data indicate that SIgA cann interact with DC not via CD89 but via carbohydrate-recognizing receptors such as MR. .
Materialss and Methods

Biochemicals Biochemicals
Alexaa Fluor™ 488 protein labeling kit was obtained from Molecular Probes Inc. (Leiden,, the Netherlands). Conjugation of different proteins with Alexa was done accordingg to protocol supplied by the manufacturer. BSA Fraction V, FTTC-conjugated BSA,, FITC-labeled mannosylated BSA, mannan derived from Saccharomyces cerevisiae,cerevisiae, the monosaccharides D-galactose, D-glucose, L-fucose, Nacetylglucosaminee and human secretory IgA were purchased from Sigma (St. Louis, MA).. Human serum IgA was obtained from ICN Pharmaceuticals (Aurora, OH).
IsolationIsolation and culture of MoDC and CD3tf-derived DC
PBMCss were isolated by density gradient centrifugation of buffy coats from healthy donorss using Lymphoprep (Nycomed, Oslo, Norway) and were cryopreserved in liquid nitrogen.. Mononuclear cells were thawed and used immediately for immunomagnetic selectionn with Monocyte Isolation Kit (Miltenyi Biotech, France). Isolation of monocytess was performed as described by manufacturer. Purified cells were typically >95%% CD14 + as determined by flow cytometry. Too obtain MoDC, monocytes (6xl0 5 cells/well) were cultured in RPMI 1640 Glutamax-II medium containing kanamycin (100u.g/ml) and 10% PCS (Life Technologies,, Cergy, France) and supplemented with 500 U/ml rhGM-CSF and 250 U/mll rhIL-4 (both cytokines were purchased from R&D Systems, Minneapolis, MN). Inn most experiments, except where noted, MoDC were harvested for use in assays afterr 5 to 7 days in culture. Analysis by flow cytometry revealed that preparations consistedd of a homogeneous population of CDla + , CD14
|0W/ ", CD83 low/ , mannose receptorr (MR) + , HLA-DR + expressing cells. This surface marker profile is characteristicc of immature DC which are thought to efficiently take up and process exogenouss Ags.
CD34
++ hematopoietic progenitor cells were isolated from umbilical cord blood sampless and used in cultures to generate immature DC as described before (28) . In brief,, CD34 + cells were isolated from mononuclear fractions through positive selection usingg anti-CD34-coated microbeads and Midi-Macs separation columns (both from Miltenyii Biotec GmBH, Bergish Gladbach, Germany). After cryopreservation, cells weree cultured in RPMI 1640 containing 10% heat-inactivated FCS, 10 mM Hepes, 2 mMM L-glutamine, 50 DM 2-mercaptoethanol and Pen/Strep supplemented with GM-CSFF (100 ng/ml, Schering-Plough Research Institute, Kenilworth, NJ), SCF (25 ng/ml, R&D,, Abington, UK), TNF-a (2.5 ng/ml R&D) and 5% AB+ pooled human serum. Forr FACS analysis, cells were collected after 6 days of culture.
Thee CD89-expressing cell line U937 (ATCC nr. CRL-1593.2) (30) was cultured in RPMII 1640 medium supplemented with 10% FCS.
AntibodiesAntibodies and flow cytometry
Cellss were incubated for 30 minutes at 4°C in FACS buffer (PBS/0.5%BSA/0.02%azide)) with a series of FTTC-or PE-conjugated mAbs recognizingg human antigens. The following mAbs were used for immunofluorescent staining:: CDla (T6), MR (3.29B1.10), CD83 (HB15a), CD14 (My4) (all obtained fromm Coulter/hnmunotech, France), CD86 (FUN-1) and CD89 (A59) (both obtained fromm Pharmingen,San Diego, CA). The CD89 mAbs A59 and 7D7 were both shown to reactt with the membrane-proximal extracellular (EC)2 domain, whereas the blocking mAbb 2D 11 was shown to react with the EC1 domain of FcaRI (31) . Monoclonal Ab reactivee with mannose receptor (clone 19) for flow cytometry and inhibition studies of IgAA binding was purchased from Pharmingen. After washing, the cells were analyzed byy flow cytometry (Coulter EPICS XL, Coulter Electronic, Miami, FL or FACScan, BecktonDickinson,, San Jose, CA). Cells were electronically gated according to light scatterr properties in order to exclude cell debris. Data analysis was performed by WinMDII software.
BindingBinding and detection of IgA
Too examine IgA binding, 5xl0 4 DC were incubated in FACS buffer with IgA (250 fig/ml)) for 1 hour at 4°C. After washing, cells were incubated for 1 hour with PElabeledd F(ab')2 fragments of goat-anti-human IgA antibody (Southern Biotechnology, Birmingham,, AL). The stained cells were analyzed by flow cytometry. To define the specificityy of the binding of IgA to CD89, blocking studies were performed using the anti-CD899 blocking mAb 2D11. Briefly, 2D11 mAb or an isotype-matched irrelevant controll mAb was added to the cells and incubated at 4°C. After 15 minutes, IgA was addedd and the cells were stained and analyzed for IgA binding by FACS as described above. .
QuantitativeQuantitative analysis ofligand uptake by cells
Cellss were harvested and resuspended in RPMI 1640 medium (without serum) containingg 0.5% BSA. Alexa-labeled ligands or FITC-conjugated ligands (1 (J.g/ml) weree diluted in RPMI medium, then added to 5xl0 4 cells, followed by 1 hour incubationn at either 37°C or 4°C (negative control), as previously described (32) . For bindingg inhibition studies mAbs or saccharides were added at the onset of incubation. Uptakee was stopped by extensively washing the cells in ice cold medium before examinationn by flow cytometry.
ActivationActivation of DC for cytokine production and phenotypical analysis
Immaturee DC were harvested, washed extensively, and stimulated with SIgA crosslinkedd with F(ab')2 goat anti-human IgA (Southern Biotechnology, Birminghm,AL) or LPSS (lug/ml) and IFN-y (10 3 U/ml). After 20h, cells were harvested and CD86 and CD833 expression were assessed by flow cytometry. At the same time, cell-free supernatantss were collected and stored at -20°C before determination of IL-12p70, IL-6,, and IL-10 levels by ELISA (Opt EIA™ Pharmingen, San Diego, CA). The sensitivityy of IL-12p70, DL-6, and IL-10 detection was 10 pg/ml.
RNARNA isolation and RT-PCR analysis
Forr PCR analysis, total RNA was isolated using RNAzol (Campro, Veenendaal, the Netherlands),, a method based on the guanidium chloride isolation according to manufacturer'' s instructions. Quantity aiupurity of RNA preparations were determined byy measuring the OD at 260 and 280 nm. Fixed amounts of total cellular RNA (1 (ig) weree reverse transcribed into cDNA by oligo-dT priming, using M-MLV reverse transcriptasee (Gibco/Life Technologies). The amplification of cDNA by PCR was performedd using the following CD89 specific primer sets: forward 5'-gaggattcaggcacaggaag-3',, reverse 5'-tctctcctggcatcaacacc-3' (product 370 bp) and forwardd 5'-ccatgcctttcatatetgcc-3', reverse 5'-gttgtaccaaccgtagcacc-3' (product 515 bp),, and the p-actin primer set: forward 5'-ctacaatgagctgcgtgtgg-3\ reverse 5'-aaggaaggctggaagagtgc-3'' (product 527 bp). PCR amplification was performed under standardd conditions (50 mM KC1, 10 raM Tris-HCl pH 8.4, 2 mM MgC12,0.06 mg/ml BSA,, 0.25 mM dNTP's, 25 pmol of each primer and 1 U of Taq polymerase; Perkin Elmer,, Norwal, CO) by 35 cycles of the following scheme: 1.5 min 95 °C, 2.5 min 60 °C,, 1.5 min 72 °C, followed by 10 min of primer extension at 72 °C. PCR products weree analyzed on a 1% agarose gel containing ethidium bromide. Final results were registeredd using the Eagle eye (Stratagene, San Diego, CA).
Results s
ExpressionExpression ofCD89 on DC derived from CD34*precursor cells Att day 6, CD34 + -derived cells cultured in the presence of GM-CSF and TNF-a expressedd low but significant levels of CD89 (Fig. 1A) . With two different mAbs againstt CD89 a similar expression was found. It has been shown that CD34 + hematopoieticc progenitor cells differentiate along two distinct DC pathways based on thee reciprocal expression of CDla or CD14 antigens (33) . To better characterize CD89 expressionn on the two CD34 + -derived DC populations a triple staining was performed allowingg specific analysis of both CD14 + /CDla" and CD147CDla + expressing cells. Interestingly,, the CDla + precursors expressed lower levels of CD89 compared to the CD14 ++ precursors (Fig. IB) . Expression remained low until the stage of fully differentiatedd DC was reached at day 12 of culture (data not shown). The CD14 + -precursorss have features of dermal DC and blood DC (33) and are likely linked to the monocyticc lineage. + precursor cells were isolatedd from cord blood and cultured in GM-CSF plus TNF-a as described in Materials and Methods. Att day 6 of culture, cells were analyzed for CD89 expression using two different monoclonal antibodiess as indicated. Specific staining (thin line) is compared to an overlay of isotype matched controll antibody (bold line). B, Dendritic cells derived from CD34 + precursors develop along two independentt pathways as shown by CD14 and CDla double staining. At day 6 of culture, CD89 expressionn on these subpopulations of DC was analyzed by triple staining (thin line) compared with controll antibody (bold line).
ExpressionExpression ofCD89 on CD14*-derived dendritic cells
Wee investigated regulation of CD89 expression during monocyte-derived DC differentiation.. High expression of CD89 was detected on monocytes at the onset (day 0)0) of DC culture and on the U937 cell line used as a positive control (Fig. 2A) . However,, CD89 expression was strongly downregulated upon differentiation to MoDC (Fig.. 2A) . Kinetic experiment showed that the strongest decrease at the protein level wass found between day 2 and day 6 of DC development (Fig. 2B) .
Reversee transcription (RT)-PCR analysis showed a similar decrease in CD89 mRNAA expression during DC development (Fig. 3) . Comparable results were found withh two different primer pairs, resulting in the expected size of PCR products, excludingg alternative splicing or contamination of chromosomal DNA. RT-PCR of the myeloidd cell line U937 was used as a positive control. Figuree 3. PCR analysis of CD89 expressionn during development from monocytee to MoDC. Total RNA was isolatedd from monocytes before and duringg culture in GM-CSF plus IL-4 att indicated time points. Total RNA wass reverse transcribed, and PCR forr CD89 and P-actin were performedd using specific primer sets.. Shown is the ethidium bromide stainingg of PCR products analyzed onn a 1 % agarose gel.
SIgASIgA binds to MoDC but the binding is not mediated via CD89
Thee IgA binding potential of MoDC was analyzed by flow cytometry. The cell line U9377 was taken along as a positive control. Incubation of U937 cells or MoDC with serumm IgA revealed high binding of serum IgA to U937 cells but minimal binding to MoDCC (Fig. 4A) , which is compatible with higher CD89 expression on U937 cells as comparedd to MoDC (Fig. 2A) . We next studied SIgA binding to U937 cells or MoDC. Inn this case, SIgA showed better binding to MoDC than to U937 cells (Fig. 4A) . To determinee whether the binding of SIgA to MoDC was mediated by CD89, cells were exposedd to SIgA in the presence and absence of the anti-CD89 blocking mAb 2D11 andd subsequently assessed for binding of IgA. The anti-CD89 blocking mAb 2D11 did nott reduce the binding of SIgA to MoDC, suggesting the involvement of another receptorr (Fig. 4B) . Binding of serum IgA to U937 cells could nearly completely be blockedd by the 2D11 mAb (Fig. 4B) . No inhibition was found with an isotype-matched controll antibody. 
HumanHuman dendritic cells efficiently internalize SIgA
Too study the fate of SIgA bound to MoDC we analyzed the uptake of IgA by immature MoDC.. The cells were incubated with Alexa-labeled ligands at either 37°C or 4°C, as describedd previously (33) . Uptake of SIgA by MoDC after incubation for 1 h at 37°C wass more efficient than using the same concentration of serum IgA (Fig. 5A) . Labelingg occurred only at 37°C, and not at 4°C, suggesting that the ligand is internalizedd by MoDC at 37°C. No labeling was found after incubation of U937 cells (Fig.. 5B) resentative experimentt out of four is shown. .
UptakeUptake of SIgA can be inhibited by some monosaccharides and Abs against mannosemannose receptor
Sincee the secretory component (SC) in SIgA is abundantly glycosylated (19) , we hypothesizedd that a receptor with lectin-like properties may be required for binding andd internalization of SIgA. To further characterize the interaction of SIgA with DC, Alexa-labeledd uptake of SIgA and BSA was measured in the presence of 100 mM monosaccharidess (Fig. 6) . Uptake of SIgA was blocked by mannose (Man) and fucose (Fuc),, and to a lesser extent by N-acetylglucosamine (NAcGlc). Galactose (Gal) was unablee to inhibit uptake of SIgA. None of the monosaccharides were able to inhibit the uptakee of BSA, which is in line with the fact that DC take up BSA via fluid phase endocytosis. .
Thee pattern of inhibition of SIgA internalization is consistent with uptake being mediatedd by mannose receptor (MR), as shown previously (34) . High expression of MRR could be detected on immature MoDC, as has been described in previous studies (9),, whereas U937 cells completely lack surface expression of MR (Fig. 7A) . Internalizationn of SIgA by MoDC in the presence of 10 u.g/ml blocking Ab against MRR was only partially inhibited (Fig. 7B) . Percentage of inhibition of SIgA uptake by MoDCC did not change using blocking MR Abs at higher concentration (data not shown).. The anti-CD89 blocking mAb 2D 11 did not reduce SIgA uptake by MoDC (Fig.. 7B) , which is in line with binding studies depicted in Fig. 4 . 
BindingBinding and uptake of SIgA does not induce dendritic cell activation or maturation
Wee next investigated whether internalization of SIgA by DC would induce DC activationn and maturation, as described for serum IgA (35) . Cross-linking of SIgA failedd to activate DC as the expression of CD86 did not change (Fig. 8A ) and CD83 wass not induced (data not shown). As a positive control, DC incubated with LPS plus IFN-yy showed increased CD83 and CD86 expression (Fig. 8A ). In addition, we examinedd whether preincubation of DC with SIgA-complexes could induce DC to producee cytokines. No increased production of IL-10, IL-12p70, or IL-6 by DC could bee detected after SIgA cross-linking, while LPS plus IFN-y induced strong IL-12p70 andd IL-6 and low IL-10 production by the same DC (Fig. 8B) . Boldd line histograms depict specific Ab staining; thin line histograms depict control. B, Culture supernatantss of MoDC described above were collected and assayed for IL-6, IL-10, and IL-12p70 usingg specific ELISA. Dotted line indicates detection limit of ELISA for EL-10 and IL-12p70 respectively.. < Indicates below detection limit. One representative experiment out of three is shown.
Discussion n
Thee most abundant isotype of antibody in secretions is SIgA and its role in the mucosall immune system is very important. It provides an immune barrier to keep exogenouss substances, like microbial pathogens, from penetrating the mucosae. In orderr to keep homeostasis IgA should not trigger inappropriate inflammation. In the presentt study, we show for the first time that SIgA binds to DC, which play a crucial rolee in the immune system (36) . In addition, we show that SIgA is efficiently taken up byy DC and that this internalization is primarily mediated via mannose receptor without inducingg DC maturation.
AA better understanding of IgA-mediated mucosal immunity requires insights into thee interaction between IgA and receptors present at mucosal surfaces. A number of differentt cell types have been previously shown to bind IgA, but only one receptor, specificc for IgA, has been cloned. The expression of FcotRI (CD89) seems to be largelyy restricted to cells of the myeloid lineage (20, 26, 27) . In the present study, we showw low levels of CD89 expression on MoDC and the CD14 + -expressing subpopulationn of CD34 + -derived DC but we could not detect CD89 expression on the CDla ++ subpopulation of CD34 + -derived DC that resemble Langerhans cells. Our data aree in line with recent in vitro studies that showed CD89 expression on a subpopulationn of MoDC resembling dermal DC but absence of CD89 on monocytederivedd Langerhans cell-type DC (35) . In addition, in vivo studies on frozen skin sectionss showed presence of CD89 on dermal DC but no staining of CD89 on Langerhanss cells (35) .
Too further investigate the interaction of IgA with DC we concentrated on MoDC becausee they represent a more homogeneous cell population and they can be obtained moree easily. Our data suggest that CD89 on MoDC is not involved in SIgA binding becausee this binding could not be inhibited by the functional blocking CD89 Ab 2D11. Thee fact that SIgA bound to MoDC suggests that another receptor for IgA exists on MoDCC next to CD89. We found higher binding of SIgA to MoDC than serum IgA, whichh might implicate either a stronger affinity of SIgA for the receptor, higher levels off cell surface expression of the receptor or higher specificity of the receptor for SIgA.
Interestingly,, MoDC efficiently internalized SIgA and this uptake could be partially inhibitedd by ligands known to interact with MR. Lack of complete inhibition indicates thatt secondary mechanisms for uptake of SIgA may be involved, like macropinocytosiss or another receptor. As MR is highly efficient in uptake and recyclingg we cannot rule out the possibility that the blocking Ab itself is internalized ass well. The complete lack of SIgA uptake by U937 cells might be explained by the factt that they do not express MR or that the cells miss the internalization machinery thatt DC do have.
Recentlyy several new C-type lectins, like DC immunoreceptor (DCIR), Langerin, DC-specificc ICAM-3 grabbing non-integrin (DC-SIGN), DC-associated C-type lectin-22 (Dectin-2), and C-type lectin receptor 1 (CLEC-1) have been described to be specificallyy expressed by DC (reviewed in 37). Interestingly, DCIR has the capacity to bindd glycosylated ligands and DC-SIGN and Langerin display mannose-binding capacity.. Whether these C-type lectin receptors play a role in SIgA binding and uptake byy DC needs further investigation.
Itt has been shown that Fc receptors such as Fey receptor types I (CD64) and II (CD32)) (12) (13) (14) , FceR type I (15, 16) , and FcotR type I (35) are able to mediate endocytosiss of immune complexes for antigen-presentation by DCs. This internalizationn process leads to activation that further allows migration and final maturationn of the DC. No cross-linking of SIgA was needed for internalization into MoDCC in our studies. In addition, we could not induce upregulation of co-stimulatory molecules,, like CD86 or CD83, nor induce MoDC to secrete cytokines after SIgA cross-linkingg with goat anti-human IgA, suggesting that uptake of SIgA did not lead to maturationn of DC.
Recentt studies showed that uptake of glycosylated antigen was mediated by mannosee receptor and that the glycosylated form of the antigen failed to prime Th cells (38) .. It could be possible that uptake of the heavily glycosylated SIgA by DC in our studiess may in a similar way be transported to the T cell areas, where the SIgA-bound antigenn could be presented without induction of maturation of the DC. Previous studiess showed that the use of immature DC results in antigen-specific inhibition of effectorr T cell functions or induction of IL-10-producing CD4 + T cells after repetitive stimulationn with immature DC (39, 40) . In addition, a subpopulation of DC was shown too transport apoptotic intestinal epithelial cells and migrate constitutively to T cell areass of mesenteric lymph nodes in the absence of any antigenic or inflammatory stimulii (18) . These immature DC containing self-Ag were suggested to play a role in inducingg and maintaining peripheral self-tolerance.
Thee in vivo relevance of our findings remains to be established. It is not clear how inn vitro generated DC are related to in vivo populations of DC. There is evidence however,, mat CD14 + cells can differentiate into DC in vivo (41) and can even be recruitedd into mucosal tissues, particularly under inflammatory conditions (2, 42) . In addition,, expression of MR by DC populations in situ has been controversial and needs furtherr investigation (43, 44) . Although SIgA and mucosal DC seem to be present in differentt body compartments and occurence of trace levels of SIgA in the circulation is nott a regular finding in healthy individuals (45) , transepithelial transport of SIgA via MM cells (46) or retrograde transport via vesicles (47) , suggests that SIgA could interact withh DC at mucosal surfaces. Moreover, mucosal DC can open tight junctions between epitheliall cells and send their dendrites outside the epithelium to sample the gut lumen (48) . .
Inn conclusion, we have shown that immature DC can very efficiently take up SIgA independentt of CD89 but via a C-type lectin pathway, without the induction of DC maturationn or activation. Therefore, we hypothesize that SIgA not only plays an antiinflammatoryy role by adhering to microbes in the intestinal lumen but may also modulatee mucosal immune responses.
